HOPE™ Nebulizer – Aerosol Therapy for Adult and Pediatric Patients
Delivers outstanding nebulizer performance
with patented Heliox port
The HOPE Nebulizer has proven to be a cost effective solution for delivery of continuous medication for the treatment of moderate to severe life threatening asthma and COPD. The HOPE is a high output nebulizer used for delivery of aerosolized medications and diagnostic formulations. It provides additional hydration for patients to loosen secretions when extended therapy is required.
The HOPE is a refillable, closed dilution, high output, large volume continuous medication nebulizer. The flow design and 200 ml reservoir allow for up to 8 hours of nebulized medication delivery at 25 ml/hr. The HOPE delivers 1 to 8 hours of continuous medication with 2.5 MMAD. The output at 25 ml/hr delivers >60% particles in the respirable range at 10 lpm flow. With the addition of supplemental Heliox, the HOPE provides a 50 ml/hr output with >75% particles in the respirable range with 15 lpm supplemental 80/20 Heliox delivered through the auxiliary port.
The HOPE has become the gold standard for the delivery of continuous nebulization and Heliox therapy. Heliox has been reported to build a therapeutic bridge in severe asthma and COPD until conventional medications have had time to take effect. It is no wonder the competition has reconfigured their products to emulate the B&B HOPE Nebulizer. B&B first introduced the patented supplemental port for Heliox delivery in a closed dilution nebulizer, greatly enhancing the performance of the HOPE Nebulizer. HOPE leads the market in simplicity and outstanding nebulizer performance in a Large Volume Continuous Medication Nebulizer.